Identification of CD8 + CD25 + Foxp3 + suppressive T cells in colorectal cancer tissue
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Background: The antitumoral immune response is one determinant of colorectal cancer (CRC) outcome. Recent work suggests that Foxp3 + CD25 + CD4 + regulatory T cells (T4reg) might hamper effective immunosurveillance of emerging cancer cells and impede effective immune responses to established tumours. In this descriptive study, we analysed blood and tissue regulatory T cell populations in patients with CRC. Methods: Blood and tissue regulatory Foxp3 + T cells from 40 patients with CRC were compared to regulatory Foxp3 + T cells from normal colonic tissue and from blood of 26 healthy volunteers. Flow cytometry was used to quantify and phenotype all Foxp3 + T cell populations. Correlations were sought with the tumour stage and with micro-invasive status. The suppressive capacity of regulatory Foxp3 + T cells was assessed by their effect on CD4 + CD25 − T cell proliferation in vitro and by their capacity to inhibit cytokine production by conventional T cells. Results: We found a significant increase of CD8 + CD25 + Foxp3 + cells (T8reg) in blood and CRC tissue; their phenotype was close to that of T4reg. T8reg cells infiltrating CRC were activated, as suggested by increased cytoxic T lymphocyte-associated antigen-4, glucocorticoid-induced tumour necrosis factor-related protein, and transforming growth factor (TGF)β1 expression compared to T8reg from normal autologous colonic tissue. Moreover, T8reg were able to suppress CD4 + CD25 − T cell proliferation and Th1 cytokine production ex vivo, demonstrating that tumour-infiltrating T8reg have strong suppressive capacities. T8reg numbers correlated with the tumour stage and with micro-invasive status. Finally, interleukin 6 and TGFβ1 synergistically induced the generation of CD8 + CD25 + Foxp3 + T cells ex vivo. Conclusions: We have identified a new regulatory T cell population (CD8 + Foxp3 + ) in colorectal tumours. After isolation from cancer tissue these CD8 + Foxp3 + cells demonstrated strong immunosuppressive properties in vitro. These data suggest that these cells may contribute to tumoral immune escape and disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Cancer incidence, mortality and prevalence worldwide
Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
The power and the promise of DNA methylation markers
Laird, P. W. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1045 · Cited by 1,562
Natural versus adaptive regulatory T cells
Bluestone, J. A., & Abbas, A. K. (2003) · Nature Reviews Immunology · doi:10.1038/nri1032 · Cited by 1,323
The role of IL-6 and STAT3 in inflammation and cancer
Hodge, D. R., Hurt, E. M., & Farrar, W. L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.016 · Cited by 950
Ghiringhelli, F., Puig, P. E., Roux, S., Parcellier, A., Schmitt, E., Solary, E., Kroemer, G., Martin, F., Chauffert, B., & Zitvogel, L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050463 · Cited by 776
Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus
Watanabe, N., Wang, Y.-H., Lee, H. K., Ito, T., Wang, Y.-H., Cao, W., & Liu, Y.-J. (2005) · Nature · doi:10.1038/nature03886 · Cited by 771
Generation of Human CD8 T Regulatory Cells by CD40 Ligand–activated Plasmacytoid Dendritic Cells
Gilliet, M., & Liu, Y.-J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011603 · Cited by 638
Sharma, S., Yang, S.-C., Zhu, L., Reckamp, K., Gardner, B., Baratelli, F., Huang, M., Batra, R. K., & Dubinett, S. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0141 · Cited by 506
IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-κB activation
Puccetti, P., & Grohmann, U. (2007) · Nature Reviews Immunology · doi:10.1038/nri2163 · Cited by 453
Liu, V. C., Wong, L. Y., Jang, T., Shah, A. H., Park, I., Yang, X., Zhang, Q., Lonning, S., Teicher, B. A., & Lee, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2883 · Cited by 453
Sather, B. D., Treuting, P., Perdue, N., Miazgowicz, M., Fontenot, J. D., Rudensky, A. Y., & Campbell, D. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070081 · Cited by 406
Curti, A., Pandolfi, S., Valzasina, B., Aluigi, M., Isidori, A., Ferri, E., Salvestrini, V., Bonanno, G., Rutella, S., Durelli, I., et al. (2007) · Blood · doi:10.1182/blood-2006-07-036863 · Cited by 396
Cosmi, L., Liotta, F., Lazzeri, E., Francalanci, M., Angeli, R., Mazzinghi, B., Santarlasci, V., Manetti, R., Vanini, V., Romagnani, P., et al. (2003) · Blood · doi:10.1182/blood-2003-04-1320 · Cited by 383
Plasmacytoid Dendritic Cells Induce CD8+ Regulatory T Cells In Human Ovarian Carcinoma
Wei, S., Kryczek, I., Zou, L., Daniel, B., Cheng, P., Mottram, P., Curiel, T., Lange, A., & Zou, W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4043 · Cited by 379
Dhodapkar, M. V., & Steinman, R. M. (2002) · Blood · doi:10.1182/blood.v100.1.174 · Cited by 363
CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer
Kiniwa, Y., Miyahara, Y., Wang, H. Y., Peng, W., Peng, G., Wheeler, T. M., Thompson, T. C., Old, L. J., & Wang, R.-F. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0842 · Cited by 352
Essential Roles of CD8+CD122+ Regulatory T Cells in the Maintenance of T Cell Homeostasis
Rifa'i, M., Kawamoto, Y., Nakashima, I., & Suzuki, H. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040395 · Cited by 309
Krambeck, A. E., Thompson, R. H., Dong, H., Lohse, C. M., Park, E. S., Kuntz, S. M., Leibovich, B. C., Blute, M. L., Cheville, J. C., & Kwon, E. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600937103 · Cited by 305
Beyer, M., Kochanek, M., Giese, T., Endl, E., Weihrauch, M. R., Knolle, P. A., Classen, S., & Schultze, J. L. (2006) · Blood · doi:10.1182/blood-2005-09-3671 · Cited by 301
CENTENO, A. M. (1951) · PubMed · Cited by 272
IL-6 involvement in epithelial cancers
Schafer, Z. T., & Brugge, J. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci34237 · Cited by 269
Valzasina, B., Piconese, S., Guiducci, C., & Colombo, M. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4217 · Cited by 259
Filaci, G., Fenoglio, D., Fravega, M., Ansaldo, G., Borgonovo, G., Traverso, P., Villaggio, B., Ferrera, A., Kunkl, A., Rizzi, M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4323 · Cited by 228
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas
Le Gouvello, S., Bastuji-Garin, S., Aloulou, N., Mansour, H., Chaumette, M.-T., Berrehar, F., Seikour, A., Charachon, A., Karoui, M., Leroy, K., et al. (2008) · Gut · doi:10.1136/gut.2007.123794 · Cited by 214
Clarke, S. L., Betts, G. J., Plant, A., Wright, K. L., El-Shanawany, T. M., Harrop, R., Torkington, J., Rees, B. I., Williams, G. T., Gallimore, A. M., et al. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000129 · Cited by 213
Yang, Z.-Z., Novak, A. J., Ziesmer, S. C., Witzig, T. E., & Ansell, S. M. (2007) · Blood · doi:10.1182/blood-2007-03-082578 · Cited by 206
Xystrakis, E., Dejean, A. S., Bernard, I., Druet, P., Liblau, R., Gonzalez-Dunia, D., & Saoudi, A. (2004) · Blood · doi:10.1182/blood-2004-03-1214 · Cited by 206
Yamazaki, S., Bonito, A. J., Spisek, R., Dhodapkar, M., Inaba, K., & Steinman, R. M. (2007) · Blood · doi:10.1182/blood-2007-05-088831 · Cited by 194
Ling, K. L., Pratap, S., Bates, G. J., Singh, B., Mortensen, N. J. M., George, B. D., Warren, B. F., Piris, J., Roncador, G., Fox, S. B., et al. (2007) · PubMed · Cited by 191
Cosmi, L., Liotta, F., Angeli, R., Mazzinghi, B., Santarlasci, V., Manetti, R., Lasagni, L., Vanini, V., Romagnani, P., Maggi, E., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3302 · Cited by 167
Induction of a distinct CD8 Tnc17 subset by transforming growth factor-β and interleukin-6
Liu, S., Tsai, J.-P., Shen, C., Sher, Y., Hsieh, C.-L., Yeh, Y.-C., Chou, A., Chang, S.-R., Hsiao, K.-N., Yu, F.-W., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0207111 · Cited by 140
Lyakh, L. A., Sanford, M. E., Chekol, S., Young, H. A., & Roberts, A. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2061 · Cited by 131
In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer
Loddenkemper, C., Schernus, M., Noutsias, M., Stein, H., Thiel, E., & Nagorsen, D. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-52 · Cited by 129
Johnson, B. F., Clay, T. M., Hobeika, A. C., Lyerly, H. K., & Morse, M. A. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.4.449 · Cited by 124
CD8 T suppressor cells are back to the game: are they players in autoimmunity?
Filaci, G., & Suciu‐Foca, N. (2002) · Autoimmunity Reviews · doi:10.1016/s1568-9972(02)00065-4 · Cited by 107
Specific control of immunity by regulatory CD8 T cells.
XiaoleiTang, TrevorRFSmith, & Kumar, V. (2005) · PubMed · Cited by 70
An integrative model of regulation centered on recognition of TCR peptide/MHC complexes
Kumar, V., & Sercarz, E. E. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820109.x · Cited by 63
Brozek, W., Bises, G., Girsch, T., Cross, H., Kaiser, H., & Peterlik, M. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.07.014 · Cited by 62
Ahmadzadeh, M., Antony, P. A., & Rosenberg, S. A. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3180336787 · Cited by 41
Sugita, S., Futagami, Y., Horie, S., & Mochizuki, M. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.07.015 · Cited by 40
Cited by
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Zheng, C., Zheng, L., Yoo, J.-K., Guo, H., Zhang, Y., Guo, X., Kang, B., Hu, R., Huang, J. Y., Zhang, Q., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.035 · Cited by 2,152
Immune infiltration in human tumors: a prognostic factor that should not be ignored
Pagès, F., Galon, J., Dieu-Nosjean, M.-C., Tartour, E., Sautès-Fridman, C., & Fridman, W.-H. (2010) · Oncogene · doi:10.1038/onc.2009.416 · Cited by 1,087
The polarization of immune cells in the tumour environment by TGFβ
Flavell, R. A., Sanjabi, S., Wrzesinski, S. H., & Licona-Limón, P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2808 · Cited by 940
“CD8 + regulatory T cells are induced under immunosuppressive conditions such as the tumour microenvironmen”
Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
Saadoun, D., Rosenzwajg, M., Joly, F., Six, A., Carrat, F., Thibault, V., Sene, D., Cacoub, P., & Klatzmann, D. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105143 · Cited by 762
Self-citationTerme, M., Pernot, S., Marcheteau, E., Sandoval, F., Benhamouda, N., Colussi, O., Dubreuil, O., Carpentier, A. F., Tartour, E., & Taieb, J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2325 · Cited by 684
Metadata
- Authors
- Chaput, N., Louafi, S., Bardier, A., Charlotte, F., Vaillant, J.-C., Ménégaux, F., Rosenzwajg, M., Lemoine, F., Klatzmann, D., & Taieb, J.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2008-11-20
- Volume
- 58
- Issue
- 4
- Pages
- 520-529
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2135917116
- Cited by
- 264
- References
- 48
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.